The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis-Reference-Cited by-同舟云学术

The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Published:2020-09 Issue:5 Volume:14 Page:983-990
ISSN:1871-4021
Container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews
language:en
Short-container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Author:

Pranata Raymond^ORCID,Permana Hikmat,Huang Ian^ORCID,Lim Michael Anthonius^ORCID,Soetedjo Nanny Natalia M.,Supriyadi Rudi,Soeroto Arto Yuwono,Alkatiri Amir Aziz,Firman Doni,Lukito Antonia Anna

Publisher

Elsevier BV

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference46 articles.

1. Coronavirus disease (COVID-19) situation report – 145;World Health Organization,2020

2. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Chen;Lancet,2020

3. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 – systematic review, meta-analysis, and meta-regression;Pranata;J Stroke Cerebrovasc Dis,2020

4. Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19;Pranata;Int J Tubercul Lung Dis,2020

5. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression;Pranata;J Renin-Angiotensin-Aldosterone Syst JRAAS,2020

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital;Hypertension Research;2024-04-26

2. Overreactive macrophages in SARS-CoV-2 infection: The effects of ACEI;International Immunopharmacology;2023-11

3. Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity;Revista Portuguesa de Cardiologia;2023-04

4. Discontinuation of Renin–Angiotensin System Inhibitors During the Early Stage of the COVID-19 Pandemic;American Journal of Hypertension;2023-03-24

5. Effect of continuing the use of renin–angiotensin system inhibitors on mortality in patients hospitalized for coronavirus disease 2019: a systematic review, meta-analysis, and meta-regression analysis;BMC Infectious Diseases;2023-01-24